[Translation] A multicenter, randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of Yuping Tongqiao tablets in the treatment of persistent allergic rhinitis (lung and spleen deficiency syndrome)
进一步评价玉屏通窍片治疗持续性变应性鼻炎(肺脾两虚证)的有效性和安全性,为申报注册提供依据。
[Translation]
Further evaluate the effectiveness and safety of Yuping Tongqiao Tablets in the treatment of persistent allergic rhinitis (lung and spleen deficiency syndrome) to provide a basis for registration application.
[Translation] A multicenter, randomized, double-blind, dose-finding, placebo-controlled phase II clinical trial to evaluate the efficacy and safety of Yuping Tongqiao tablets in the treatment of persistent allergic rhinitis (lung and spleen deficiency syndrome)
To preliminarily evaluate the effectiveness of Yuping Tongqiao Tablets in treating persistent allergic rhinitis (lung and spleen deficiency syndrome);
To explore the action characteristics and advantageous dose of Yuping Tongqiao Tablets in treating persistent allergic rhinitis;
To evaluate the safety of Yuping Tongqiao Tablets in patients with persistent allergic rhinitis;
To provide a basis for further clinical research design.
[Translation] A randomized, double-blind, parallel-controlled, multicenter phase IIb clinical study to evaluate the efficacy and safety of Lianhua Dingchuan tablets in the treatment of chronic persistent bronchial asthma
To explore the symptom-improving effect of Lianhua Dingchuan tablets on chronic persistent stage of bronchial asthma; to explore the improving effect on hot asthma syndrome in chronic persistent stage of bronchial asthma; to explore the reasonable dosage of Lianhua Dingchuan tablets in the treatment of chronic persistent stage of bronchial asthma (hot asthma syndrome); to observe the safety and adverse reactions of Lianhua Dingchuan tablets.
Epiberberine, a natural bioactive protoberberine alkaloid, was totally synthesized in short, convenient and low-cost, four-step reactions including cyclization, condensation, reduction, and ring-closing, with an overall yield of 26.1%.
100 Deals associated with Beijing Yiling Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Beijing Yiling Pharmaceutical Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.